Osteogenic effects of simvastatin-loaded mesoporous titania thin films by Lopez Alvarez, Miriam et al.
Biomedical Materials
ACCEPTED MANUSCRIPT
Osteogenic effects of simvastatin-loaded mesoporous titania thin films
To cite this article before publication: Miriam Lopez-Alvarez et al 2017 Biomed. Mater. in press https://doi.org/10.1088/1748-605X/aa95f1
Manuscript version: Accepted Manuscript
Accepted Manuscript is “the version of the article accepted for publication including all changes made as a result of the peer review process,
and which may also include the addition to the article by IOP Publishing of a header, an article ID, a cover sheet and/or an ‘Accepted
Manuscript’ watermark, but excluding any other editing, typesetting or other changes made by IOP Publishing and/or its licensors”
This Accepted Manuscript is © 2017 IOP Publishing Ltd.
 
During the embargo period (the 12 month period from the publication of the Version of Record of this article), the Accepted Manuscript is fully
protected by copyright and cannot be reused or reposted elsewhere.
As the Version of Record of this article is going to be / has been published on a subscription basis, this Accepted Manuscript is available for reuse
under a CC BY-NC-ND 3.0 licence after the 12 month embargo period.
After the embargo period, everyone is permitted to use copy and redistribute this article for non-commercial purposes only, provided that they
adhere to all the terms of the licence https://creativecommons.org/licences/by-nc-nd/3.0
Although reasonable endeavours have been taken to obtain all necessary permissions from third parties to include their copyrighted content
within this article, their full citation and copyright line may not be present in this Accepted Manuscript version. Before using any content from this
article, please refer to the Version of Record on IOPscience once published for full citation and copyright details, as permissions will likely be
required. All third party content is fully copyright protected, unless specifically stated otherwise in the figure caption in the Version of Record.
View the article online for updates and enhancements.
This content was downloaded from IP address 186.33.250.36 on 26/10/2017 at 15:00
Osteogenic effects of simvastatin-loaded mesoporous 
titania thin films 
Miriam López-Álvarez
1*
, Vanesa López-Puente
2
, Cosme Rodríguez-Valencia
1
, 
Paula C. Angelomé
3
, Luis M. Liz-Marzán
4,5,6
, Julia Serra
1
, Isabel Pastoriza-
Santos
2
, Pío González
1
 
1
New Materials Group, Applied Physics Dpt, IISGS, University of Vigo, Spain 
2
Departamento de Química-Física, CINBIO, Universidade de Vigo, 36310, Spain 
3
Gerencia Química, Centro Atómico Constituyentes, Comisión Nacional de 
Energía Atómica, CONICET, Av. Gral Paz 1499, B1650KNA, San Martín, 
Buenos Aires, Argentina 
4
CIC biomaGUNE, Paseo de Miramón 182, 20014 Donostia-San Sebastián, Spain 
5
Ikerbasque Basque Foundation for Science, 48013 Bilbao, Spain 
6
CIBER de Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, 20014 
Donostia-San Sebastián, Spain 
E-mail addresses: miriammsd@uvigo.es, vanelope@uvigo.es, cosme@uvigo.es, 
angelome@cnea.gov.ar, llizmarzan@cicbiomagune.es, jserra@uvigo.es, 
pastoriza@uvigo.es, pglez@uvigo.es 
Corresponding author: Miriam López Álvarez, New Materials Group, Applied 
Physics Dpt., School of Industrial Engineering, Campus Lagoas-Marcosende, 
University of Vigo, 36310, Spain 
E-mail: miriammsd@uvigo.es 
Telephone: +34 986130158 // Fax: +34 986812201 
Running head: Simvastatin-loaded mesoporous titania thin films 
Page 1 of 23 AUTHOR SUBMITTED MANUSCRIPT - BMM-101878.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
Abstract 
The use of statins in the field of bone regeneration is under current investigation due to 
the existing demand for non-toxic anabolic agents capable of enhancing bone formation 
in cases of substantial loss. Simvastatin, a coenzyme currently prescribed in clinics to 
inhibit cholesterol biosynthesis, has been proven to promote osteogenic differentiation by 
stimulating bone formation and inhibiting osteoclasts activity. We present the loading of 
simvastatin in mesoporous TiO2 thin films toward combining the pro-osteogenic 
properties of this molecule with the demonstrated bioactivity of titania. TiO2 thin films 
processing and characterization were carried out, as well as evaluation of MC3T3-E1 pre-
osteoblasts viability when directly incubated with different concentrations of simvastatin, 
followed by the analysis of osteogenic activity promoted by simvastatin upon loading in 
the thin films. The accessible porosity of 36 % quantified on the 95±5 nm thick 
mesoporous thin films, together with pore diameters of 5.5 nm, necks between pores of 
2.8 nm and interpore distances of 12±2 nm allow the loading of the simvastatin molecule, 
as confirmed by FTIR spectroscopy. Simvastatin was found to promote MC3T3-E1 pre-
osteoblasts viability at concentrations ≤ 0.01 g/L, with a cytotoxicity threshold of 0.05 
g/L. We additionally found that film loadings with 0.001 g/L simvastatin promotes 
statistically higher MC3T3-E1 pre-osteoblast proliferation whereas a higher concentration 
of 0.01 g/L leads to statistically higher osteogenic activity (ALP synthesis), after 21 days 
of incubation, as compared to unloaded films. These results demonstrate the potential of 
simvastatin local administration based on bioactive mesoporous thin films to promote 
pro-osteogenic properties. By focusing this strategy on the coating of metallic prostheses, 
the supply of simvastatin to the target tissue can be favored and risks of systemic side 
effects will be reduced while enhancing the osteointegration of the implants. 
Keywords: simvastatin, mesoporous titania, thin films, osteogenic activity, drug delivery.  
1. Introduction 
The main strategy in clinics to restore functionality in cases of critically damaged bone tissue, 
such as in osteoporosis (Kanis et al 2013) or periodontal diseases (Sayar et al 2016), comprises 
its replacement by metallic alloys. These metallic implants (such as Ti6Al4V alloy) present 
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appropriate mechanical properties and biocompatibility. However, limitations in terms of 
bioactivity and osteointegration are commonly experienced, which give rise to problems at 
implant fixation, apart from infection and inflammation cases after the implant surgery (Xia et 
al 2012). Thus, to increase the bioactivity and osteointegration of these implants, cell-
biomaterial interactions must be improved. These interactions have been demonstrated to be 
highly influenced by the stiffness, topography and chemical composition of the implant surface 
(Bellino et al 2013). Bioactive materials favor direct surface formation of apatite in vivo, which 
subsequently enables bone bonding (Karlsson et al 2015a). Among the wide variety of bioactive 
materials, titania is considered as a highly suitable biocompatible material for bone-anchoring 
implants exhibiting little or no toxicity, both in vitro and in vivo (Gertler et al 2010).  
Moreover, these ceramics can be deposited as thin films over metallic alloys to provide the cells 
with a bioactive surface. Evaporation-induced self-assembly (EISA) is a very versatile chemical 
methodology (Brinker et al 1999) by which mesoporous titania thin films can be easily obtained 
onto a wide variety of substrates with a tunable mesoscopic topography and controlled 
wettability, porosity and chemical properties, based on a combination of sol gel chemistry, 
supramolecular templates and surface modifications (Soler-Illia et al 2012, Sanchez et al 2008). 
These mesoporous titania thin films have been proven to promote in vivo enhanced initial bone 
contact and improved distribution of bone tissue. This is due to the highly ordered arrays of 
monodisperse pores, high specific surface areas and bioactive properties (Meretoja et al 2007), 
which influence and eventually lead to the control of osteoblast adhesion and proliferation. The 
improvement of the initial attachment of cells onto the implant surfaces promotes enhanced 
integration of the implant and longer term stability (Bellino et al 2013).  
Mesoporous materials have additionally shown great potential in drug delivery applications to 
provide and maintain drug concentrations within the therapeutic window for the desired period 
of time. The unique features of mesoporous biomaterials, such as high specific surface area, and 
tunable pore-size (with pore diameters between 2 and 50 nm), -volume and -symmetry (ordered 
distribution), allow drug release to occur in a highly reproducible and predictable manner 
(Karlsson et al 2015a). This is of great interest since it is believed that the local drug loading of 
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antibiotics, anti-inflammatory medicines and growth factors, commonly prescribed orally, 
intravenously, intramuscularly or topically after the implant surgery, contributes to enhancing 
the efficiency of these drugs, while the classic systemic routes hinder them from reaching the 
interface of implants and tissues (Xia et al 2012). The controlled local delivery of drugs at the 
implant might bring an efficient therapeutic treatment, since it would administrate the drug 
directly at the targeted cells for a prolonged time period, and thus reduce the risk of systemic 
side effects (Karlsson et al 2015a).  
In the specific case of bone-anchoring implants, it has been demonstrated that their 
osseointegration capacity can be improved by using an inbuilt drug delivery system, such as 
modified mesoporous composites and mesoporous bioactive glasses, which can locally 
administer drugs. For instance, Karlsson et al (2015b) proved that the local loading of the 
osteoporosis bisphosphonate drug alendronate, clinically used by oral administration, promoted 
more extensive bone formation. Different antibiotics were also loaded at hosting molecules for 
efficient prevention of infections, as demonstrated by Xia et al (2012) by loading cephalothin in 
titanium dioxide coatings. Anti-inflammatory drugs (ibuprofen) were also tested by McMaster 
et al (2012) in collagen-templated bioactive titanium dioxide porous networks. 
Simvastatin, a hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is 
known to inhibit cholesterol biosynthesis and is currently clinically prescribed for that purpose. 
Several recent studies have demonstrated that this cholesterol-lowering drug also promotes 
osteogenic differentiation, stimulating bone formation in vitro and in vivo (Maeda et al 2001, 
Mundy et al 1999, Yin et al 2012). The mechanism is thought to be related with the promotion 
of mitochondrial function (cell proliferation) and stimulation of the expression of the bone 
morphogenic protein-2 (BMP-2), a growth factor involved in osteoblast activation. In addition, 
simvastatin seems to participate in osteoclast inhibition by stimulating neovascularization 
(increasing the secretion of vascular endothelial growth factor) (Kheirallah and Almeshaly 
2016). 
The topical administration of simvastatin has been proposed to improve the pro-angiogenic and 
pro-osteogenic properties of bioglass putty in rat calvaria critical-size defects without significant 
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inflammation, stimulating BMP-2 and VEGF mRNA expression in osteoblasts (Allon et al 
2012) compared to bioglass without topical simvastatin up to 4 weeks of implantation. The 
effects of simvastatin on osteoblastic differentiation in vitro were evaluated by Maeda et al 
(2001) to demonstrate that simvastatin enhances alkaline phosphatase (ALP) activity and 
mineralization in a dose- and time-dependent fashion. Mundy et al (1999) injected simvastatin 
(together with lovastatin) subcutaneously in calvaria of mice, resulting in increased bone 
formation; moreover when simvastatin was orally administered in rats, increased cancellous 
bone volume was also quantified. The use of statins is of great current interest as there is a clear 
need for non-toxic anabolic agents that will substantially increase bone formation in people who 
have already suffered substantial bone loss (Mundy et al 1999). 
However, the systemic administration of statins has been related to serious side effects that can 
be avoided by means of local delivery of the molecule. Moreover, clinical studies suggest that 
orally administered statins may be degraded in the liver, so little of the drug is available to 
accumulate in bone. If higher doses of systemic applied simvastatin are provided, the risk of 
liver failure, kidney disease, rhabdomyolysis, myalgia and other side effects increase as well 
(Kheirallah and Almeshaly 2016). Therefore TiO2-based biomaterials loaded with simvastatin 
present good prospect as coatings of metallic implants that can provide a combination of local 
drug delivery and bioactivity (direct bone-bonding capability) to be used for biomedical 
applications, such as treatment and regeneration of bone defects. 
These small molecules that activate the promoter of the bone morphogenetic protein-2 gene can 
be readily loaded into the meso-porosity of titania thin films to provide metallic prosthesis with 
higher osteointegration (due to the bioactivity of the titania film) and with pro-osteogenic 
properties (due to local simvastatin loading), thereby promoting increased expression of the 
bone morphogenetic protein-2 (BMP-2) gene in bone cells. The processing and characterization 
of TiO2 mesoporous coatings, their loading with different concentrations of simvastatin as well 
as the biological response in terms of proliferation and osteogenic activity of MC3T3-E1 pre-
osteoblasts are the main objectives of the present work. 
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2. Materials and Methods 
2.1 Mesoporous thin films  
Glass discs (6 mm in diameter, Thermo Scientific) were sonicated in ethanol for 30 min and 
then copiously rinsed with Milli-Q water and stored in water until use. Titania mesoporous thin 
films were fabricated on the glass disc surfaces through the EISA approach as previously 
reported (Crepaldi et al 2003). Briefly, a precursor mixture of TiCl4 (Aldrich), Pluronic F127 
((HO(CH2CH2O)106(CH2CH(CH3)O)70(CH2CH2O)106OH), Sigma), EtOH (pure grade, ACS) and 
Milli-Q water was prepared. TiCl4/EtOH/F127/H2O mixtures presented a 1:40:0.005:10 molar 
ratio of the reagents. Then, 125 µL of the freshly prepared mixture was spin-coated (4000 rpm) 
on top of the glass discs. The deposited films were then placed in 50 % relative humidity 
chambers (obtained with a NaBr saturated solution in water) for 24 h and subjected to a 
stabilizing thermal treatment comprising two successive 24 h heating steps at 60 ºC and 120 ºC 
and a final step at 200 ºC for 2 h. The F127, acting as template, was finally removed by 
immersing the films in ethanol for 3 days. 
2.2 Physicochemical characterization 
Transmission electron microscopy (TEM) images were obtained with a JEOL JEM 1010 
microscope operating at an accelerating voltage of 100 kV. Samples for TEM were obtained by 
scratching the films from the substrate and depositing them on carbon- and FORMVAR-coated 
copper grids. Scanning electron microscopy (SEM) images from the top and the cross section of 
the films were obtained with a JEOL JSM-6700 FEG scanning electron microscope operating at 
an accelerating voltage of 10 kV.  
The porosity and pore size distribution were assessed by Environmental Ellipsometric 
Porosimetry with a SE SOPRA GES-5 spectroscopic ellipsometer in microspot configuration. 
This technique consists of performing spectroscopic ellipsometry measurements while varying 
water vapor pressure in a controlled humidity chamber. From those measurements, refractive 
index variation as a function of humidity is obtained and total accessible volume is calculated 
by using a Lorentz-Lorenz effective medium approximation. The size distribution of pores and 
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necks was determined from the adsorption and desorption branches of the isotherms, through 
the Kelvin equation, taking into account the water contact angle of the sample. The data were 
analyzed with Winelli software (Boissiere et al 2005, Soler-Illia et al 2012). 
Raman spectra were collected using a Renishaw InVia Reflex system. The spectrograph uses 
high resolution grating (1200 cm
-1
) with additional band-pass filter optics, a confocal 
microscope and a 2D-CCD camera. All measurements were made in a confocal microscope in 
backscattering geometry using a 20X objective with accumulation times of 10 s and a excitation 
laser line of 532 nm (Nd:YAG). 
Fourier transform infrared (FTIR) spectra were recorded in Transmission mode using a Nicolet 
5PCFT-IR spectrometer in the 4000−400 cm−1 range. Samples were prepared by scratching the 
film and mixing it with KBr, to form a pellet. 
2.3 Determination of cytotoxicity threshold and loading of simvastatin 
The cytotoxicity threshold was first determined in order to select the optimal simvastatin 
concentrations to be tested. Direct cell seeding of the MC3T3-E1 pre-osteoblasts (ECACC, UK) 
with a wide range of simvastatin (C25H38O5, Sigma S6196, >97 % purity) concentrations in 
ethanol (5; 1; 0.5; 0.1; 0.05; 0.01; 0.001; 0 g/L) was carried out up to 4 days of incubation. 
Thus, 20 μL aliquots from each concentration were added to the corresponding well (96 well 
microplate) and once ethanol was evaporated, 100 μL of cell suspension (1.7x105 cel/mL) in 
supplemented MEM-alpha medium (Lonza BE02-002F) were added. After 4 days of incubation, 
and without medium refreshment to maintain the simvastatin concentrations, cell proliferation 
was quantified with the Cell Proliferation Kit I (MTT assay, Roche), based on the reduction of 
the yellow tetrazolium salt MTT (3-(4,5-dimethyltiazolyl-2)-2,5-diphenyl tetrazolium bromide) 
into insoluble purple formazan crystals by the mitochondrial enzyme succinate dehydrogenase, 
only present in living cells. To this end, 10 µL of MTT labeling reagent in phosphate buffered 
saline (PBS) was added to each well for 4 hours (37 ºC, 5 % CO2). Formazan crystals were 
subsequently solubilized with 100 µL of 10% sodium dodecyl sulfate (SDS) in 0.01 M HCl. 
The plate was incubated overnight and the resulting colored solution was quantified at 595 and 
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655 nm using a Bio-Rad Model 550 microplate spectrophotometer. Four replicates per condition 
were evaluated. 
The mesoporous TiO2 thin films deposited on glass substrates were then sterilized by immersion 
in 70 % ethanol for 48 h at 2-8 ºC. After that, ethanol was removed and samples dried in a 
laminar flow chamber. The loading of TiO2 thin films with simvastatin was performed by 
addition (discs already placed in 96-well microplates) of 20 µL of simvastatin solution in 
ethanol and maintained for 48 h at 2-8 ºC. Different simvastatin concentrations, 0.01 g/L, 0.001 
g/L and 0 g/L (reference material), were tested. Finally, the samples were dried in the laminar 
flow chamber before cell seeding. Simvastatin loaded thin films with a concentration of 5 g/L 
were also characterized by using a Nicolet 5PCFT-IR spectrophotometer in the 4000−400 cm−1 
range. Samples were prepared by scratching the film and mixing it with KBr, to form a pellet. 
2.4 Biological response of simvastatin-loaded mesoporous thin films 
A concentration of 1.7x10
5
 cells/mL of MC3T3-E1 pre-osteoblasts in 100 µL of MEM-alpha 
supplemented with 10 % Fetal Bovine Serum (FBS; Lonza DE14-801E) and 1 % Antibiotic 
Antimycotic Solution with 10000 units of penicillin, 10 mg of streptomycin and 25 µg of 
amphotericin B per mL (Sigma A5955) were seeded on the TiO2 + 0.01, TiO2 + 0.001 and TiO2 
+ 0 discs. Empty wells on the microplates (Tissue Culture Polystyrene, TCPS) were also seeded 
to be used as the gold standard of the cell culture. Cells were cultured up to 21 days in a 
humidified atmosphere with 5 % CO2 at 37 ºC. To induce the differentiation to osteoblasts 2-
phospho-L-ascorbic acid trisodium salt (2 mM, Sigma 49752), β-glycerophosphate disodium 
salt hydrate (10 mM, Sigma G9422) and dexamethasone (10
-5 
M, Sigma D4902, ≥97 %) were 
added to the supplemented MEM-alpha. Culture medium was renewed every 2–3 days.  
Cell morphology was analyzed by SEM (Philips XL30) after 7 and 21 days. After each 
incubation time, cells were fixed with 2.5 % glutaraldehyde solution in PBS (Lonza BE17-
512F) for 2 h at 4 ºC. Samples were then washed three times for 30 min with PBS and 
dehydrated in graded acetone solutions (30 %, 50 %, 70 %, 80 %, 95 %) for 30 minutes in each 
solution and in absolute acetone for 1 h. After dehydration, samples were submitted to critical 
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point in CO2, at 75 atm and 31.3 ºC, mounted on metal stubs and sputter-coated with gold prior 
to their analysis using a Philips XL30 scanning electron microscope (CACTI, University of 
Vigo).  
Cell proliferation was quantified after 7 and 21 days with the Cell Proliferation Kit I (MTT 
assay, Roche), as described above. The plate was then incubated overnight and, after removing 
the discs, the resulting colored solution was quantified at 595 and 655 nm using a Bio-Rad 
Model 550 microplate spectrophotometer. Four replicates per material per condition were 
evaluated and the complete experiment was repeated twice. TiO2 discs without cell seeding 
were also incubated as blanks. 
Osteogenic activity was evaluated by quantifying the activity of the enzyme alkaline 
phosphatase (ALP) after 7 and 21 days of incubation. After each incubation time, discs were 
carefully rinsed twice with PBS and immersed in water. The cell lysates were obtained after the 
osmotic shock followed by a thermal shock by transferring the lysates from 37 to -80 ºC.  ALP 
activity was measured using a p-nitrophenol assay. Briefly, p-nitrophenyl phosphate, which is 
colorless, was hydrolyzed by alkaline phosphatase at pH 10.5 and 37 ºC to form free p-
nitrophenol, which is yellow. The reaction was stopped by adding NaOH and the absorbance 
read at 405 nm in a microplate reader (Bio-Tek, USA). The kit (Alkaline Phosphatase Assay 
Kit, Abcam) provides with ALP standards to calibrate the results and obtain the corresponding 
concentrations of enzyme (U/mL) from the absorbance data. Both cell proliferation and 
osteogenic activity protocols were also applied to the TCPS controls, as the gold standard 
reference. Four replicates were used per material per condition and the complete experiments 
were repeated twice. Discs without cell seeding were also incubated as blanks. 
2.5 Statistical analysis 
Data are presented as mean ± mean standard deviation (typical error) in error bars (n=4). 
Differences between groups were analyzed according to Student´s t-test with p<0.01 and p<0.05 
considered statistically significant (99 % and 95 % of cases, respectively).  
3. Results 
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3.1 Mesoporous thin films characterization and simvastatin loading 
Mesoporous titania thin films were fabricated on glass disks by spin coating following the EISA 
procedure (Crepaldi et al 2003). An amphiphilic block-copolymer (Pluronic F127) was 
employed as pore template and TiCl4 was used as TiO2 precursor, both dissolved in ethanol. The 
controlled evaporation of the solvent led to assembly of the Pluronic F127 into micelles and the 
condensation of the precursor, generating an ordered mesophase. Stiffening of the inorganic 
network and removal of the template required a thermal treatment and ethanol extraction. Figure 
1 shows scanning and transmission electron micrographs of the obtained thin films. Highly 
ordered pores forming a 3D cubic arrangement compatible with the Im3m space group (body 
centered cubic order, commonly obtained when using Pluronic F127 as a template (Crepaldi et 
al 2003)) were observed. The interpore distance (from center to center of neighboring pores) for 
these mesoporous films was of 12±2 nm, as determined from TEM and SEM image analysis. 
This value is in accordance with previously reported results (Crepaldi et al 2003). A film 
thickness of 95±5 nm was measured from SEM cross section images (inset in figure 1(a)). 
 
Figure 1. SEM (a) and TEM micrographs (b) of mesoporous titania thin films deposited on a 
glass disc. In (a) the inset is an image of the cross section of the same mesoporous thin film.  
The removal of Pluronic F127 upon ethanol extraction (see experimental part for details) was 
evaluated by FTIR analysis and confirmed by the absence of the strong IR signals at around 
2850-2930 cm
-1
 assigned to the C-H stretching vibration of the template (figure S1(a) in 
supporting material) (Socrates et al 2004). The crystalline structure of TiO2 was evaluated by 
Raman spectroscopy, which revealed the characteristic lines of anatase TiO2 phase at 150 (Eg), 
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194, 400 (B1g), and 636 (Eg) cm
-1
 (figure S1(b) in supporting material) (Wang et al 2013). 
However, broad of peaks at 400 and 636 cm
-1
 indicates that the titania walls present a low 
degree of crystalline order, in agreement with previous results (Angelomé PC et al 2007).  
Finally, the accessible porosity and the pore size distribution of the mesoporous thin films were 
evaluated by Environmental Ellipsometric Porosimetry (figure 2). The adsorption-desorption 
isotherms shown in figure 2(a) are characteristic of mesoporous materials and demonstrate that 
the accessible porosity of the obtained titania mesoporous thin film was around 36 %. The pore 
size distribution plotted in figure 2(b) corresponds to pores of 5.5 nm (obtained from the 
adsorption branch) and necks between the pores of 2.8 nm (obtained from desorption branch). 
The porosity and pore sizes are again in agreement with previous results obtained for calcined 
mesoporous films (Violi et al 2012), which confirms the efficiency of the extraction approach to 
eliminate the template. 
 
Figure 2. Water adsorption-desorption isotherms for a mesoporous titania thin film (a). Pore size 
(solid circles) and neck size (empty circle) distributions obtained from adsorption-desorption 
branches of isotherms through the Kelvin equation (b).  
The high porosity of the mesoporous titania thin films together with their bioactive properties 
motivated us to load the mesostructures with simvastatin. Importantly, simvastatin is a molecule 
(see figure S2 in supporting information) with dimensions smaller than the mesoporous pore 
and neck sizes. In addition, the molecule presents ester and hydroxyl groups, which are known 
to be complexing agents for mesoporous TiO2 (Angelomé and Soler-Illia 2005).The ability of 
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simvastatin to diffuse within the mesoporous thin film and attach to the TiO2 walls was 
confirmed by FTIR spectroscopy. As shown in figure 3, the FTIR spectrum of a titania thin film 
loaded with 5 g/L of simvastatin displays the characteristic FTIR signals of this molecule, 
including symmetric and asymmetric stretching vibration of C–H (2800-3000 cm-1 and 1456 
cm
-1
), esteric carbonyl C=O stretch (1695 cm
-1
) and bending of both C–O–C lactone (1265 cm-1) 
and ester (1161 cm
-1
) (Ledeti et al 2015), together with the νTiOTi vibrations of the oxide. 
 
Figure 3. FTIR spectra of simvastatin (black), a mesoporous titania thin film (red) and a 
mesoporous titania thin film loaded with simvastatin (blue).  
3.2 Biological response of simvastatin-loaded mesoporous thin films 
Figure 4 presents the direct evaluation of MC3T3-E1 pre-osteoblasts viability with a wide range 
of simvastatin concentrations from 0 g/L to 5 g/L, in the growth media. The samples with 0 g/L 
were considered as the positive control for optimal cell viability. After 4 days of incubation, 
simvastatin concentrations ≤ 0.01 g/L promoted cell viability within the same range as the 0 g/L 
(for 0.01 g/L) or statistically significantly higher (p < 0.01) (for 0.001 g/L) than both 0 g/L and 
0.01 g/L concentrations. However, higher simvastatin concentrations ≥ 0.1 g/L (from 0.1 to 5 
g/L) were found to promote low cell viability, with optical density values below 0.4 which is 
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considered as a cytotoxic level, and significantly lower cell viability (p < 0.01) than the positive 
control (0 g/L) for all cases. The 0.05 g/L samples promoted higher cell viability (> 0.4), but 
still statistically significantly lower (p<0.01) than the positive control. Therefore, taking into 
account these results, the cytotoxicity threshold for simvastatin with MC3T3-E1 pre-osteoblasts 
could be established on simvastatin concentrations ≥ 0.05 g/L. Moreover 0.01 g/L and 0.001 g/L 
were considered as the optimal simvastatin concentrations to be loaded within the mesoporous 
titania thin films, as they seemed to ensure the same levels of cell viability or higher (in case of 
0.001 g/L) than the growth medium (without simvastatin).  
 
Figure 4. MC3T3-E1 pre-osteoblasts viability after 4 days of incubation with different 
concentrations (g/L) of simvastatin in supplemented MEM-alpha growth medium. Significant 
statistical differences are presented as ** for p<0.01 (99%) and * for p<0.05 (95%).  
TiO2 thin films were then loaded with the two optimal simvastatin concentrations of 0.01 g/L 
and 0.001 g/L and incubated with MC3T3-E1 pre-osteoblasts to evaluate their proliferation and 
osteogenic activity. MC3T3-E1 pre-osteoblasts proliferation on the loaded thin film coatings 
together with the experimental controls (0 g/L and TCPS) is presented in figure 5, as a function 
of incubation time (7 and 21 days). Cell proliferation on the three tested mesoporous titania thin 
films was significantly lower (p<0.01) than on the TCPS after 7 days of incubation, where the 
optical density value above 1.0 at this latter validated the healthy stage of the cells. After 21 
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days of incubation, no statistical differences were found between cell proliferation at 0 g/L 
mesoporous titania thin films and TCPS, thereby validating the biocompatibility of the films 
together with their proper sterilization and the optimal evaporation of ethanol during the loading 
procedure (as these 0 g/L samples were subjected to the same process as the loaded ones). 
Moreover, cell proliferation increased for all tested conditions, as compared to each value at 7 
days. In more detail, cell proliferation at 0.01 g/L was significantly lower (p<0.01) than on 
0.001 g/L and 0 g/L mesoporous thin films. On the other hand, the 0.001 g/L films promoted 
significantly higher cell proliferation than the 0.01 g/L (p<0.01) and the 0 g/L (p<0.01) films. 
We therefore conclude that, loading of mesoporous titania thin films with 0.001g/L simvastatin 
significantly promoted the proliferation of MC3T3-E1 pre-osteoblasts after 21 days of 
incubation, while the cell proliferation rate in case of 0.01 g/L loading was significantly slowed 
down. 
 
Figure 5. MC3T3-E1 pre-osteoblasts proliferation on mesoporous titania thin films loaded with 
0.01 g/L, 0.001 g/L and 0 g/L of simvastatin up to 21 days of incubation. Cell proliferation for 
tissue culture polystyrene (TCPS) is also presented. 
The effect of simvastatin loaded titania thin films on cell morphology after 21 days of 
incubation was analyzed by SEM. Figure 6 shows SEM micrographs of MC3T3-E1 pre-
osteoblasts monolayers on thin films loaded with simvastatin at the 0.01 g/L (a, b), 0.001 g/L (c, 
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d) and 0 g/L (e, f). It is important to note that a cell monolayer covering the whole film surface 
was observed in all cases (figure 6a,c,e). Meanwhile, formation of complex filament networks 
and synthesis of pre-mineralized matrix were evident in 0.01 g/L (figure 6(b)) and 0 g/L (figure 
6 (f)) thin films, and less intense in the case of 0.001g/L (figure 6(d)). 
 
Figure 6. SEM micrographs of MC3T3-E1 pre-osteoblasts morphology on 0.01 g/L (a,b), 0.001 
g/L(c,d) and 0 g/L (e,f) simvastatin loaded mesoporous titania thin films after 21 days of 
incubation. 
The osteogenic activity of the MC3T3-E1 pre-osteoblasts was evaluated by quantifying the 
synthesis of the early marker alkaline phosphatase (ALP enzyme) after 7 and 21 days (figure 7). 
Thus, the dramatic and expected increase at the ALP synthesis by the cells at 21 days of 
incubation on the TCPS, compared to the value quantified at 7 days, validated the healthy stage 
of the cells and, therefore, the experiment. Focusing on the titania thin films, the absence of 
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ALP synthesis was observed at 7 days of incubation, being significantly lower (p<0.01) than in 
TCPS. A dramatic increase of ALP synthesis was also detected for the three tested titania thin 
films at 21 days of incubation, in analogy to TCPS, which proved the differentiation of the 
MC3T3-E1 pre-osteoblast like cells into osteoblasts. However differences were found between 
them, with significantly higher values for 0.01 g/L of simvastatin than for the two other films 
with lower concentrations: 0.001 (p<0.05) and 0 g/L (p<0.01). These two lower concentrations 
presented also significantly lower ALP synthesis than the TCPS (p<0.05 and p<0.01, 
respectively), while the 0.01 promoted the osteogenic activity at the same level than the gold 
standard. 
 
Figure 7. MC3T3-E1 pre-osteoblasts osteogenic activity (ALP synthesis) on mesoporous titania 
thin films loaded with 0.01 g/L, 0.001 g/L and 0 g/L of simvastatin up to 21 days of incubation. 
ALP synthesis quantified on the tissue culture polystyrene (TCPS) is also presented. 
In figure 8 the SEM analysis of the cell monolayer microstructure at 21 days of incubation on 
the 0.01g/L thin films is presented. At this time of incubation, cells are found to spread on a flat 
morphology (figure 8(a)) with abundant lamellipodia to establish cell to cell contacts covering 
the entire surface and growing directly over cell layer (figure 8(b)), being the thin film under the 
thick layer of cells. The synthesis of pre-mineralized extracellular matrix can be observed with 
the formation of a complex network of pre-collagen filaments (figure 8c,d).  
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 Figure 8. SEM micrographs of MC3T3-E1 pre-osteoblasts morphology on mesoporous titania 
thin films loaded with 0.01 g/L of simvastatin after 21 days of incubation.  
4. Discussion 
In the present work, the promotion of osteogenic activity by simvastastin upon loading in 
mesoporous titania thin films was evaluated on MC3T3-E1 pre-osteoblasts, along with the 
cytotoxicity threshold.  
In detail, simvastatin loading within mesoporous titania thin films was confirmed together with 
the physicochemical characterization of the films. The abundance of highly ordered pores 
forming a 3D cubic arrangement was proved on the mesoporous thin films of TiO2, with an 
interpore distance of 12±2 nm and a layer thickness of 95±5 nm, as presented in figure 1. The 
accessible porosity was quantified (figure 2) to be 36 %, with pore diameters of 5.5 nm and 
necks between the pores of 2.8 nm. These data, together with the simvastatin dimensions (1.2 
nm x 1.2 nm) ensure the ability of the molecule to diffuse within the pores and attach to the 
titania walls, through ester and hydroxyl groups. Simvastatin loading was confirmed by FTIR 
spectroscopy (figure 3) where νC=O, νCH and νCOC vibrations were detected, together with νTiOTi 
vibrations assigned to the mesoporous film. An enhanced osteointegration was previously 
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observed for mesoporous titania with 6 nm of pore diameter (Harmankaya et al 2013, Galli et al 
2014, Karlsson et al 2015b).  
The ability of mesoporous titania to form chemical bonds with apatite through Ca
2+
 cations 
(Karlsson et al 2014), in combination with its suitability as drug delivery system, render it 
unique properties when used as implant coatings. The loading of different bone formation 
promoters in mesoporous titania films (alendronate (Karlsson et al 2015b), raloxifene 
(Harmankaya et al 2013) or magnesium (Galli et al 2014)) has been reported. In this context,  
the loading and osteogenic activity promoted by simvastatin are of interest, as it is currently 
prescribed to inhibit cholesterol biosynthesis and already proven as a promoter of osteogenic 
differentiation (Maeda et al 2001). 
When simvastatin was directly added to the cells in growth media (figure 4) promoted MC3T3-
E1 pre-osteoblasts viability at concentrations ≤ 0.01 g/L, but inhibited viability at higher 
concentrations ≥ 0.1g/L, with a cytotoxicity threshold at 0.05 g/L. This viability trend was 
maintained upon simvastatin loading into mesoporous titania thin films. Indeed, concentrations 
of 0.01 g/L and 0.001 g/L of simvastatin promoted the MC3T3-E1 proliferation, being 
statistically higher for 0.001 g/L (figures 5 and 6), and the osteogenic activity, being statistically 
higher for 0.01 g/L (figures 7 and 8) after 21 days of incubation. Maeda et al (2001) proved 
higher levels of osteoblast differentiation and mineralization when 10
-7 
M simvastatin was 
directly added to MC3T3-E1, as compared to 10
-8
 and 10
-9 
M. In our work the highest osteoblast 
differentiation was achieved for 0.001 g/L (2.4x10
-6 
M) and 0.01 g/L (2.4x10
-5 
M) upon loading 
in the thin films. Moreover, the cytotoxicity threshold obtained when cells were directly 
incubated with simvastatin was established as 0.05 g/L (1.2x10
-4
M). These results demonstrate 
that there was still margin in vitro to enrich with higher concentrations of simvastatin for this 
cell line. 
It is important to note that despite the concentrations of statins in the bone marrow have not 
been well established yet, it is accepted that osteoblasts and osteoclasts may be exposed to very 
low concentrations (Kheirallah and Almeshaly 2016). In fact, within the strategy of local 
administration, the coating of a porous and well interconnected scaffold of TiO2 with alginate 
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hydrogel containing 10 nM of simvastatin was reported to promote the osteogenic 
differentiation of human mesenchymal stem cells (Pullisaar et al 2014). The presence of 
alginate and the entire scaffold of titania (8 mm in height and 9 mm in diameter) have surely 
contributed to these good results for such a low dose of simvastatin, against the thin film titania 
coatings (95 nm in height and 6mm in diameter) used at the present work.  
On the other hand, higher concentrations of simvastatin were also successfully evaluated in 
tibial defect of rabbit model in terms of osteointegration, bone ingrowth and neovascularization. 
Thus, Liu et al (2016) evaluated porous titanium alloy scaffolds (5 mm diameter and 6 mm 
thickness) filled with simvastatin/poloxamer 407 hydrogel with final simvastatin concentrations 
of 0.1 g/L and 0.5 g/L. A significantly increased cortical bone was quantified with the 0.5 g/L 
simvastatin group (0.5 mg), being nearly identical to that of normal cortical bone at 8 weeks.  
Moreover, in a recent review about the simvastatin influence on animal model studies (Sendyk 
et al 2016 the difficulty to equalize the optimal range of doses/concentrations of this drug was 
discussed. Successful results were found for simvastatin doses which range from 10
-4
 to 10
-7 
M, 
when directly applied on titanium implants´ surfaces or in calcium phosphate coatings, and from 
50 µg to 10 mg on oxidized surface of implants, combined with chitosan as a coating or directly 
injected in to the femurs. However, topical application has been shown to cause local 
inflammation in high doses (Sendyk et al 2016). There is, therefore, a lack of consensus in the 
literature in relation to the effective doses of simvastatin, even when being tested alone directly 
with cells, without any carrier. Moreover, it seems to strongly depend on the drug release 
patterns from the loading material or administration strategy used.  
5. Conclusions 
The ability of simvastatin to be loaded in mesoporous titania thin films was demonstrated 
together with its effectiveness in terms of pro-osteogenic activity. In detail, 36 % of accessible 
porosity with pore diameters of 5.5 nm interpore distances of 12±2 nm in TiO2 thin films with 
thicknesses of 95±5 nm, were proven to favor the diffusion of simvastatin within the pores and 
its attachment to the titania walls through ester and hydroxyl groups. Simvastatin concentrations 
≤ 0.01 g/L were proven to promote MC3T3-E1 pre-osteoblasts viability, while concentrations ≥ 
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0.1 g/L inhibited it, being the cytotoxicity threshold established as 0.05 g/L. Finally, a 
concentration of 0.001 g/L of simvastatin upon loaded on the mesoporous titania thin films 
promoted statistically higher MC3T3-E1 proliferation and a concentration of 0.01 g/L 
statistically higher osteogenic activity after 21 days in comparison to unloaded films. The in 
vitro effectiveness of simvastatin loading in mesoporous titania thin films was demonstrated, 
with potential application in the field of bone regeneration, especially when an implant is 
required. This work opens the possibility of using TiO2 mesoporous thin films as carriers for 
local delivery of simvastatin to coat metallic prosthesis and provide them with pro-osteogenic 
activity and better osteointegration. Deep evaluation on the release pattern of this molecule is 
required as well as the performance in vivo of metallic implants coated with these simvastatin-
loaded TiO2 thin films. 
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